Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karlyn A Martin

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Thrombosis Research|February 4, 2018
Anticoagulant drug choice in patients who have had bariatric surgery - Presently, DOACs are not the preferred choiceStephan Moll, Karlyn A Martin
JAMA|April 30, 2025
Factor V LeidenKarlyn A Martin, Mary Cushman
Research and Practice in Thrombosis and Haemostasis|September 2, 2025
Time to move beyond risk assessment models for ambulatory cancer-associated thrombosisKarlyn A Martin, Chris Holmes
Thrombosis and Haemostasis|October 9, 2023
Venous Thromboembolism and Obesity: Moving Toward a Better Understanding of the Population-Attributable RiskKarlyn A Martin, Neil A Zakai
Journal of General Internal Medicine|September 20, 2024
Words Matter: a Call to Remove "Sickler" from Medical Lingo in the United StatesKarlyn A Martin, Charles N Mininger
Hematology. American Society of Hematology. Education Program|December 10, 2021
Chronic thromboembolic pulmonary hypertension: anticoagulation and beyondKarlyn A Martin, Michael J Cuttica
Blood Advances|May 16, 2025
Weighing the evidence on GLP1s and venous thromboembolismDamon E Houghton, Karlyn A Martin
JAMA Oncology|May 6, 2021
Risk, Racial Disparity, and Outcomes Among Patients With Cancer and COVID-19 InfectionVaibhav Kumar, Megan Grant, Karlyn A Martin
Thrombosis Research|October 20, 2022
Barriers and facilitators to preventing venous thromboembolism in oncology practiceKarlyn A Martin, Madison J Lyleroehr, Kenzie A Cameron
Research and Practice in Thrombosis and Haemostasis|November 21, 2022
Pulmonary embolism-related mortality during the COVID-19 pandemic: Data from the United StatesKarlyn A Martin, Katharine Harrington, Xiaoning Huang, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Thrombosis Research|February 4, 2018
Anticoagulant drug choice in patients who have had bariatric surgery - Presently, DOACs are not the preferred choiceStephan Moll, Karlyn A Martin
JAMA|April 30, 2025
Factor V LeidenKarlyn A Martin, Mary Cushman
Research and Practice in Thrombosis and Haemostasis|September 2, 2025
Time to move beyond risk assessment models for ambulatory cancer-associated thrombosisKarlyn A Martin, Chris Holmes
Thrombosis and Haemostasis|October 9, 2023
Venous Thromboembolism and Obesity: Moving Toward a Better Understanding of the Population-Attributable RiskKarlyn A Martin, Neil A Zakai
Journal of General Internal Medicine|September 20, 2024
Words Matter: a Call to Remove "Sickler" from Medical Lingo in the United StatesKarlyn A Martin, Charles N Mininger
Hematology. American Society of Hematology. Education Program|December 10, 2021
Chronic thromboembolic pulmonary hypertension: anticoagulation and beyondKarlyn A Martin, Michael J Cuttica
Blood Advances|May 16, 2025
Weighing the evidence on GLP1s and venous thromboembolismDamon E Houghton, Karlyn A Martin
JAMA Oncology|May 6, 2021
Risk, Racial Disparity, and Outcomes Among Patients With Cancer and COVID-19 InfectionVaibhav Kumar, Megan Grant, Karlyn A Martin
Thrombosis Research|October 20, 2022
Barriers and facilitators to preventing venous thromboembolism in oncology practiceKarlyn A Martin, Madison J Lyleroehr, Kenzie A Cameron
Research and Practice in Thrombosis and Haemostasis|November 21, 2022
Pulmonary embolism-related mortality during the COVID-19 pandemic: Data from the United StatesKarlyn A Martin, Katharine Harrington, Xiaoning Huang, et al.
Pageof 4